ROR2 and B-cell chronic lymphocytic leukemia: Wnt5a has been shown to induce the ROR1/ROR2 heterooligomers to activate signalling in chronic lymphocytic leukaemia (CLL), and neither ROR1 nor ROR2 alone was efficient in triggering the optimal downstream cascade30.